212 related articles for article (PubMed ID: 28689687)
1. The effect of the muscarinic M
Vingerhoets C; Bakker G; van Dijk J; Bloemen OJN; Wang Y; Chan RCK; Booij J; van Amelsvoort TAMJ
Eur Neuropsychopharmacol; 2017 Sep; 27(9):854-864. PubMed ID: 28689687
[TBL] [Abstract][Full Text] [Related]
2. Influence of muscarinic M
Vingerhoets C; Bakker G; Schrantee A; van der Pluijm M; Bloemen OJN; Reneman L; Caan M; Booij J; van Amelsvoort TAMJ
Psychiatry Res Neuroimaging; 2019 Aug; 290():5-13. PubMed ID: 31252222
[TBL] [Abstract][Full Text] [Related]
3. The muscarinic M
Bakker G; Vingerhoets C; Bloemen OJN; Sahakian BJ; Booij J; Caan MWA; van Amelsvoort TAMJ
Neuroimage Clin; 2020; 27():102278. PubMed ID: 32563036
[TBL] [Abstract][Full Text] [Related]
4. Relationship between muscarinic M
Bakker G; Vingerhoets C; Boucherie D; Caan M; Bloemen O; Eersels J; Booij J; van Amelsvoort T
Neuroimage Clin; 2018; 18():713-719. PubMed ID: 29560312
[TBL] [Abstract][Full Text] [Related]
5. Human electrophysiological correlates of learned irrelevance: effects of the muscarinic M1 antagonist biperiden.
Klinkenberg I; Blokland A; Riedel W; Sambeth A
Int J Neuropsychopharmacol; 2012 Nov; 15(10):1375-85. PubMed ID: 22094124
[TBL] [Abstract][Full Text] [Related]
6. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
7. Biperiden Challenge Model in Healthy Elderly as Proof-of-Pharmacology Tool: A Randomized, Placebo-Controlled Trial.
Bakker C; van Esdonk MJ; Stuurman RFE; Borghans LGJM; de Kam ML; van Gerven JMA; Groeneveld GJ
J Clin Pharmacol; 2021 Nov; 61(11):1466-1478. PubMed ID: 34021607
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study.
Liang CS; Ho PS; Shen LJ; Lee WK; Yang FW; Chiang KT
Schizophr Res; 2010 Jun; 119(1-3):138-44. PubMed ID: 20299191
[TBL] [Abstract][Full Text] [Related]
9. Biperiden selectively induces memory impairment in healthy volunteers: no interaction with citalopram.
Sambeth A; Riedel WJ; Klinkenberg I; Kähkönen S; Blokland A
Psychopharmacology (Berl); 2015 Jun; 232(11):1887-97. PubMed ID: 25466702
[TBL] [Abstract][Full Text] [Related]
10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
11. Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects.
Wezenberg E; Verkes RJ; Sabbe BG; Ruigt GS; Hulstijn W
Psychopharmacology (Berl); 2005 Sep; 181(3):582-94. PubMed ID: 16041534
[TBL] [Abstract][Full Text] [Related]
12. Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia.
Ogino S; Miyamoto S; Tenjin T; Kitajima R; Ojima K; Miyake N; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Tatsunami S; Kubota H; Kaneda Y; Yamaguchi N
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):78-83. PubMed ID: 20828595
[TBL] [Abstract][Full Text] [Related]
13. Biperiden Selectively Impairs Verbal Episodic Memory in a Dose- and Time-Dependent Manner in Healthy Subjects.
Borghans L; Sambeth A; Blokland A
J Clin Psychopharmacol; 2020; 40(1):30-37. PubMed ID: 31834098
[TBL] [Abstract][Full Text] [Related]
14. Biperiden (an M1 antagonist) reduces memory consolidation of cocaine-conditioned place preference.
Zacarias MS; Ramos AC; Alves DR; Galduróz JC
Neurosci Lett; 2012 Apr; 513(2):129-31. PubMed ID: 22336140
[TBL] [Abstract][Full Text] [Related]
15. Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers.
Veselinović T; Vernaleken I; Janouschek H; Kellermann T; Paulzen M; Cumming P; Gründer G
Psychopharmacology (Berl); 2015 May; 232(9):1607-17. PubMed ID: 25373869
[TBL] [Abstract][Full Text] [Related]
16. The muscarinic system, cognition and schizophrenia.
Carruthers SP; Gurvich CT; Rossell SL
Neurosci Biobehav Rev; 2015 Aug; 55():393-402. PubMed ID: 26003527
[TBL] [Abstract][Full Text] [Related]
17. Effects of biperiden (cholinergic muscarinic m1/m4 receptor antagonist) on ethanol conditioned place preference in mice.
Palombo P; Engi SA; Yokoyama TS; Bezerra AG; Curado DF; Anésio A; Leão RM; Santos PCJL; Cruz FC; Galduróz JCF
Neurosci Lett; 2021 Feb; 745():135551. PubMed ID: 33346074
[TBL] [Abstract][Full Text] [Related]
18. Comparison of pro-amnesic efficacy of scopolamine, biperiden, and phencyclidine by using passive avoidance task in CD-1 mice.
Malikowska N; Sałat K; Podkowa A
J Pharmacol Toxicol Methods; 2017 Jul; 86():76-80. PubMed ID: 28412329
[TBL] [Abstract][Full Text] [Related]
19. Effects of biperiden and acute tryptophan depletion and their combination on verbal word memory and EEG.
Borghans LG; Blokland A; Sambeth A
Psychopharmacology (Berl); 2017 Apr; 234(7):1135-1143. PubMed ID: 28210777
[TBL] [Abstract][Full Text] [Related]
20. Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats.
Roldán G; Bolaños-Badillo E; González-Sánchez H; Quirarte GL; Prado-Alcalá RA
Neurosci Lett; 1997 Jul; 230(2):93-6. PubMed ID: 9259472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
